Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

CVS vs MCK vs UNH vs CAH

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
CVS
CVS Health Corporation

Medical - Healthcare Plans

HealthcareNYSE • US
Market Cap$111.40B
5Y Perf.+33.2%
MCK
McKesson Corporation

Medical - Distribution

HealthcareNYSE • US
Market Cap$92.15B
5Y Perf.+374.1%
UNH
UnitedHealth Group Incorporated

Medical - Healthcare Plans

HealthcareNYSE • US
Market Cap$335.60B
5Y Perf.+21.3%
CAH
Cardinal Health, Inc.

Medical - Distribution

HealthcareNYSE • US
Market Cap$43.59B
5Y Perf.+238.7%

CVS vs MCK vs UNH vs CAH — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
CVS logoCVS
MCK logoMCK
UNH logoUNH
CAH logoCAH
IndustryMedical - Healthcare PlansMedical - DistributionMedical - Healthcare PlansMedical - Distribution
Market Cap$111.40B$92.15B$335.60B$43.59B
Revenue (TTM)$407.90B$403.43B$449.71B$250.55B
Net Income (TTM)$2.93B$4.76B$12.04B$1.56B
Gross Margin13.9%3.6%18.8%3.7%
Operating Margin1.5%1.5%4.2%0.9%
Forward P/E12.2x19.3x20.2x17.9x
Total Debt$93.59B$7.39B$78.39B$9.35B
Cash & Equiv.$8.51B$5.69B$24.36B$3.87B

CVS vs MCK vs UNH vs CAHLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

CVS
MCK
UNH
CAH
StockMay 20May 26Return
CVS Health Corporat… (CVS)100133.2+33.2%
McKesson Corporation (MCK)100474.1+374.1%
UnitedHealth Group … (UNH)100121.3+21.3%
Cardinal Health, In… (CAH)100338.7+238.7%

Price return only. Dividends and distributions are not included.

Quick Verdict: CVS vs MCK vs UNH vs CAH

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CVS leads in 3 of 7 categories, making it the strongest pick for valuation and capital efficiency and dividend income and shareholder returns. McKesson Corporation is the stronger pick specifically for growth and revenue expansion and operational efficiency and capital deployment. UNH and CAH also each lead in at least one category. As sector peers, any of these can serve as alternatives in the same allocation.
CVS
CVS Health Corporation
The Insurance Pick

CVS carries the broadest edge in this set and is the clearest fit for value and dividends.

  • Lower P/E (12.2x vs 17.9x)
  • 3.1% yield, vs UNH's 2.4%
  • +34.7% vs UNH's -3.2%
Best for: value and dividends
MCK
McKesson Corporation
The Growth Play

MCK is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.

  • Rev growth 16.2%, EPS growth 14.9%, 3Y rev CAGR 10.8%
  • 348.1% 10Y total return vs CAH's 160.8%
  • 16.2% revenue growth vs CAH's -1.9%
  • 5.7% ROA vs CVS's 1.1%, ROIC 5.4% vs 5.0%
Best for: growth exposure and long-term compounding
UNH
UnitedHealth Group Incorporated
The Insurance Pick

UNH is the clearest fit if your priority is quality.

  • 2.7% margin vs CAH's 0.6%
Best for: quality
CAH
Cardinal Health, Inc.
The Income Pick

CAH is the clearest fit if your priority is income & stability and sleep-well-at-night.

  • Dividend streak 20 yrs, beta 0.03, yield 1.1%
  • Lower volatility, beta 0.03, current ratio 0.94x
  • Beta 0.03, yield 1.1%, current ratio 0.94x
  • Beta 0.03 vs UNH's 0.59
Best for: income & stability and sleep-well-at-night
See the full category breakdown
CategoryWinnerWhy
GrowthMCK logoMCK16.2% revenue growth vs CAH's -1.9%
ValueCVS logoCVSLower P/E (12.2x vs 17.9x)
Quality / MarginsUNH logoUNH2.7% margin vs CAH's 0.6%
Stability / SafetyCAH logoCAHBeta 0.03 vs UNH's 0.59
DividendsCVS logoCVS3.1% yield, vs UNH's 2.4%
Momentum (1Y)CVS logoCVS+34.7% vs UNH's -3.2%
Efficiency (ROA)MCK logoMCK5.7% ROA vs CVS's 1.1%, ROIC 5.4% vs 5.0%

CVS vs MCK vs UNH vs CAH — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

CVSCVS Health Corporation
FY 2025
Pharmacy Revenue
58.9%$229.0B
Premiums
34.6%$134.8B
Front Store Revenue
5.5%$21.5B
Product and Service, Other
1.0%$3.9B
MCKMcKesson Corporation
FY 2025
U.S. Pharmaceutical Segment
91.3%$327.7B
International Segment
4.1%$14.7B
Medical-Surgical Solutions Segment
3.2%$11.4B
Prescription Technology Solutions
1.5%$5.2B
UNHUnitedHealth Group Incorporated
FY 2025
Unitedhealthcare
94.4%$332.4B
Optumhealth
5.6%$19.8B
CAHCardinal Health, Inc.
FY 2025
Pharmaceutical Member
91.9%$204.6B
GMPD
5.7%$12.6B
Other Operating Segment
2.4%$5.4B

CVS vs MCK vs UNH vs CAH — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCVSLAGGINGCAH

Income & Cash Flow (Last 12 Months)

UNH leads this category, winning 4 of 6 comparable metrics.

UNH is the larger business by revenue, generating $449.7B annually — 1.8x CAH's $250.5B. Profitability is closely matched — net margins range from 2.7% (UNH) to 0.6% (CAH). On growth, CAH holds the edge at +11.0% YoY revenue growth, suggesting stronger near-term business momentum.

MetricCVS logoCVSCVS Health Corpor…MCK logoMCKMcKesson Corporat…UNH logoUNHUnitedHealth Grou…CAH logoCAHCardinal Health, …
RevenueTrailing 12 months$407.9B$403.4B$449.7B$250.5B
EBITDAEarnings before interest/tax$10.5B$6.8B$23.2B$3.2B
Net IncomeAfter-tax profit$2.9B$4.8B$12.0B$1.6B
Free Cash FlowCash after capex$7.4B$6.0B$19.7B$4.4B
Gross MarginGross profit ÷ Revenue+13.9%+3.6%+18.8%+3.7%
Operating MarginEBIT ÷ Revenue+1.5%+1.5%+4.2%+0.9%
Net MarginNet income ÷ Revenue+0.7%+1.2%+2.7%+0.6%
FCF MarginFCF ÷ Revenue+1.8%+1.5%+4.4%+1.8%
Rev. Growth (YoY)Latest quarter vs prior year+6.2%+6.0%+2.0%+11.0%
EPS Growth (YoY)Latest quarter vs prior year+63.1%+37.0%+0.7%-19.5%
UNH leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

CVS leads this category, winning 4 of 6 comparable metrics.

At 27.9x trailing earnings, UNH trades at a 56% valuation discount to CVS's 62.8x P/E. On an enterprise value basis, CVS's 13.1x EV/EBITDA is more attractive than MCK's 18.7x.

MetricCVS logoCVSCVS Health Corpor…MCK logoMCKMcKesson Corporat…UNH logoUNHUnitedHealth Grou…CAH logoCAHCardinal Health, …
Market CapShares × price$111.4B$92.1B$335.6B$43.6B
Enterprise ValueMkt cap + debt − cash$196.5B$93.8B$389.6B$49.1B
Trailing P/EPrice ÷ TTM EPS62.81x29.25x27.95x28.72x
Forward P/EPrice ÷ next-FY EPS est.12.19x19.28x20.19x17.94x
PEG RatioP/E ÷ EPS growth rate0.75x
EV / EBITDAEnterprise value multiple13.11x18.74x16.70x16.01x
Price / SalesMarket cap ÷ Revenue0.28x0.26x0.75x0.20x
Price / BookPrice ÷ Book value/share1.47x3.31x
Price / FCFMarket cap ÷ FCF14.27x17.63x20.88x23.56x
CVS leads this category, winning 4 of 6 comparable metrics.

Profitability & Efficiency

MCK leads this category, winning 7 of 9 comparable metrics.

MCK delivers a 3.0% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $4 for CVS. UNH carries lower financial leverage with a 0.77x debt-to-equity ratio, signaling a more conservative balance sheet compared to CVS's 1.24x. On the Piotroski fundamental quality scale (0–9), MCK scores 6/9 vs CVS's 5/9, reflecting solid financial health.

MetricCVS logoCVSCVS Health Corpor…MCK logoMCKMcKesson Corporat…UNH logoUNHUnitedHealth Grou…CAH logoCAHCardinal Health, …
ROE (TTM)Return on equity+3.9%+3.0%+11.5%
ROA (TTM)Return on assets+1.1%+5.7%+3.9%+2.8%
ROICReturn on invested capital+5.0%+5.4%+9.2%+33.8%
ROCEReturn on capital employed+6.1%+30.5%+9.7%+19.2%
Piotroski ScoreFundamental quality 0–95666
Debt / EquityFinancial leverage1.24x0.77x
Net DebtTotal debt minus cash$85.1B$1.7B$54.0B$5.5B
Cash & Equiv.Liquid assets$8.5B$5.7B$24.4B$3.9B
Total DebtShort + long-term debt$93.6B$7.4B$78.4B$9.3B
Interest CoverageEBIT ÷ Interest expense2.11x33.79x4.71x6.38x
MCK leads this category, winning 7 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

Evenly matched — CVS and MCK and CAH each lead in 2 of 6 comparable metrics.

A $10,000 investment in MCK five years ago would be worth $38,689 today (with dividends reinvested), compared to $9,743 for UNH. Over the past 12 months, CVS leads with a +34.7% total return vs UNH's -3.2%. The 3-year compound annual growth rate (CAGR) favors CAH at 31.5% vs UNH's -7.1% — a key indicator of consistent wealth creation.

MetricCVS logoCVSCVS Health Corpor…MCK logoMCKMcKesson Corporat…UNH logoUNHUnitedHealth Grou…CAH logoCAHCardinal Health, …
YTD ReturnYear-to-date+10.6%-8.5%+10.6%-9.5%
1-Year ReturnPast 12 months+34.7%+4.6%-3.2%+22.0%
3-Year ReturnCumulative with dividends+36.6%+106.4%-19.9%+127.3%
5-Year ReturnCumulative with dividends+17.0%+286.9%-2.6%+235.7%
10-Year ReturnCumulative with dividends+3.5%+348.1%+220.6%+160.8%
CAGR (3Y)Annualised 3-year return+11.0%+27.3%-7.1%+31.5%
Evenly matched — CVS and MCK and CAH each lead in 2 of 6 comparable metrics.

Risk & Volatility

Evenly matched — CVS and CAH each lead in 1 of 2 comparable metrics.

CAH is the less volatile stock with a 0.03 beta — it tends to amplify market swings less than UNH's 0.59 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CVS currently trades 98.5% from its 52-week high vs MCK's 75.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricCVS logoCVSCVS Health Corpor…MCK logoMCKMcKesson Corporat…UNH logoUNHUnitedHealth Grou…CAH logoCAHCardinal Health, …
Beta (5Y)Sensitivity to S&P 5000.05x0.04x0.59x0.03x
52-Week HighHighest price in past year$88.63$999.00$395.52$233.60
52-Week LowLowest price in past year$58.35$637.00$234.60$137.75
% of 52W HighCurrent price vs 52-week peak+98.5%+75.3%+93.5%+79.3%
RSI (14)Momentum oscillator 0–10069.316.275.933.2
Avg Volume (50D)Average daily shares traded7.4M757K7.9M1.7M
Evenly matched — CVS and CAH each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — CVS and UNH each lead in 1 of 2 comparable metrics.

Analyst consensus: CVS as "Buy", MCK as "Buy", UNH as "Buy", CAH as "Buy". Consensus price targets imply 34.8% upside for CAH (target: $250) vs 4.2% for UNH (target: $385). For income investors, CVS offers the higher dividend yield at 3.06% vs MCK's 0.36%.

MetricCVS logoCVSCVS Health Corpor…MCK logoMCKMcKesson Corporat…UNH logoUNHUnitedHealth Grou…CAH logoCAHCardinal Health, …
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuy
Price TargetConsensus 12-month target$95.20$1006.50$385.43$249.67
# AnalystsCovering analysts41315233
Dividend YieldAnnual dividend ÷ price+3.1%+0.4%+2.4%+1.1%
Dividend StreakConsecutive years of raises0172520
Dividend / ShareAnnual DPS$2.67$2.69$8.70$2.04
Buyback YieldShare repurchases ÷ mkt cap0.0%+3.4%+1.7%+1.8%
Evenly matched — CVS and UNH each lead in 1 of 2 comparable metrics.
Key Takeaway

UNH leads in 1 of 6 categories (Income & Cash Flow). CVS leads in 1 (Valuation Metrics). 3 tied.

Best OverallCVS Health Corporation (CVS)Leads 1 of 6 categories
Loading custom metrics...

CVS vs MCK vs UNH vs CAH: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is CVS or MCK or UNH or CAH a better buy right now?

For growth investors, McKesson Corporation (MCK) is the stronger pick with 16.

2% revenue growth year-over-year, versus -1. 9% for Cardinal Health, Inc. (CAH). UnitedHealth Group Incorporated (UNH) offers the better valuation at 27. 9x trailing P/E (20. 2x forward), making it the more compelling value choice. Analysts rate CVS Health Corporation (CVS) a "Buy" — based on 41 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — CVS or MCK or UNH or CAH?

On trailing P/E, UnitedHealth Group Incorporated (UNH) is the cheapest at 27.

9x versus CVS Health Corporation at 62. 8x. On forward P/E, CVS Health Corporation is actually cheaper at 12. 2x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — CVS or MCK or UNH or CAH?

Over the past 5 years, McKesson Corporation (MCK) delivered a total return of +286.

9%, compared to -2. 6% for UnitedHealth Group Incorporated (UNH). Over 10 years, the gap is even starker: MCK returned +348. 1% versus CVS's +3. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — CVS or MCK or UNH or CAH?

By beta (market sensitivity over 5 years), Cardinal Health, Inc.

(CAH) is the lower-risk stock at 0. 03β versus UnitedHealth Group Incorporated's 0. 59β — meaning UNH is approximately 1630% more volatile than CAH relative to the S&P 500. On balance sheet safety, UnitedHealth Group Incorporated (UNH) carries a lower debt/equity ratio of 77% versus 124% for CVS Health Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — CVS or MCK or UNH or CAH?

By revenue growth (latest reported year), McKesson Corporation (MCK) is pulling ahead at 16.

2% versus -1. 9% for Cardinal Health, Inc. (CAH). On earnings-per-share growth, the picture is similar: Cardinal Health, Inc. grew EPS 87. 0% year-over-year, compared to -62. 0% for CVS Health Corporation. Over a 3-year CAGR, UNH leads at 11. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — CVS or MCK or UNH or CAH?

UnitedHealth Group Incorporated (UNH) is the more profitable company, earning 2.

7% net margin versus 0. 4% for CVS Health Corporation — meaning it keeps 2. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UNH leads at 4. 2% versus 1. 0% for CAH. At the gross margin level — before operating expenses — UNH leads at 18. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is CVS or MCK or UNH or CAH more undervalued right now?

On forward earnings alone, CVS Health Corporation (CVS) trades at 12.

2x forward P/E versus 20. 2x for UnitedHealth Group Incorporated — 8. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CAH: 34. 8% to $249. 67.

08

Which pays a better dividend — CVS or MCK or UNH or CAH?

All stocks in this comparison pay dividends.

CVS Health Corporation (CVS) offers the highest yield at 3. 1%, versus 0. 4% for McKesson Corporation (MCK).

09

Is CVS or MCK or UNH or CAH better for a retirement portfolio?

For long-horizon retirement investors, Cardinal Health, Inc.

(CAH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 03), 1. 1% yield, +160. 8% 10Y return). Both have compounded well over 10 years (CAH: +160. 8%, UNH: +220. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between CVS and MCK and UNH and CAH?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: CVS is a mid-cap income-oriented stock; MCK is a mid-cap high-growth stock; UNH is a large-cap quality compounder stock; CAH is a mid-cap quality compounder stock. CVS, UNH, CAH pay a dividend while MCK does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

CVS

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Dividend Yield > 1.2%
Run This Screen
Stocks Like

MCK

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Dividend Yield > 0.5%
Run This Screen
Stocks Like

UNH

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Dividend Yield > 0.9%
Run This Screen
Stocks Like

CAH

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Dividend Yield > 0.5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform CVS and MCK and UNH and CAH on the metrics below

Revenue Growth>
%
(CVS: 6.2% · MCK: 6.0%)
P/E Ratio<
x
(CVS: 62.8x · MCK: 29.2x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.